Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-014117
Filing Date
2025-02-14
Accepted
2025-02-14 16:16:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7933
  Complete submission text file 0001104659-25-014117.txt   9584
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Subject) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-40503 | Film No.: 25629036
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 380 LAFAYETTE STREET 6TH FLOOR NEW YORK NY 10003
Business Address 380 LAFAYETTE STREET 6TH FLOOR NEW YORK NY 10003 212 475-8335
Select Equity Group, L.P. (Filed by) CIK: 0001592643 (see all company filings)

EIN.: 463465710 | State of Incorp.: DE
Type: SCHEDULE 13G/A